United Therapeutics (UTHR -0.7%) says its wholly owned subsidiary, United Therapeutics Europe,...

|About: United Therapeutics Corpora... (UTHR)|By:, SA News Editor

United Therapeutics (UTHR -0.7%) says its wholly owned subsidiary, United Therapeutics Europe, has received approval from French regulators for its New Drug Application for Intravenous Remodulin for the treatment of pulmonary arterial hypertension.